Home/Filings/4/0001626533-24-000007
4//SEC Filing

Jeffs David 4

Accession 0001626533-24-000007

CIK 0001493712other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 1:10 PM ET

Size

8.6 KB

Accession

0001626533-24-000007

Insider Transaction Report

Form 4
Period: 2023-12-29
Jeffs David
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Shares

    2023-12-29$0.01/sh+7,500,000$52,50081,459,726 total(indirect: Daughter)
  • Purchase

    Common Shares

    2023-12-29$0.01/sh+7,500,000$52,50088,959,726 total(indirect: Son)
  • Award

    Common Shares

    2023-12-29$0.01/sh+73,959,726$517,71873,959,726 total
Footnotes (2)
  • [F1](1) Reporting Person acquired 73,959,726 shares on settlement of $517,718 owed by the Issuer to the Reporting Person.
  • [F2]Immediate family members of the Reporting Person acquired a total of 15,000,000 shares on settlement of $105,000 owed by the Issuer to the immediate family members. The inclusion of these shares shall not be deemed an admission of beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.

Issuer

Cell MedX Corp.

CIK 0001493712

Entity typeother

Related Parties

1
  • filerCIK 0001298416

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 1:10 PM ET
Size
8.6 KB